HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Redken seeking Facebook blondes

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal salon brand invites fair-haired women to upload their photo to its 10,000 Blondes application on social networking site Facebook.com; participants can learn about Redken products formulated specially for blond hair - which tends to be drier and more fragile and "can look duller as shine is less reflective," the company says - and enter to win a free sample from brand's Blonde Glam hair-care collection. "We know that our consumers love to use social media as a tool for beauty inspiration or to share their latest looks," says Rachel Weiss, Redken's senior director of interactive. "Photos are also a huge part of social activities on Facebook and we want Redken to be a part of this social media rise ... and this launch was the perfect opportunity to leverage this trend." Newest additions to Blonde Glam line are Perfect Platinum and Rich Vanilla color enhancers fortified with Redken's Interbond Conditioning System and Crystal Shine Complex, which deliver mica, grapefruit extract and grape seed oil, among other actives, to nourish and protect hair and maintain salon effects

You may also be interested in...



Chinese Firms Up Their Game In Novel Flu Antiviral Development

Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.

Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016221

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel